All News

The investment comes from NorthEdge’s £125M SME fund. 

Pharmapack 2022 is just around the corner and judging for its annual awards is already underway. Every year a jury of industry experts assesses a range of products making waves in packaging and drug delivery and ultimately crowns a handful of winners a...

The site will produce customisable bioprocess container systems. 

Samsung Biologics has full ownership over Samsung Bioepis after purchasing Biogen’s stake

This oral solution allows for high iron absorption while minimising digestive issues 

The investment will expand operations over two years at facilities in Taiwan and Canada

Both companies will integrate their products to improve data management and automation in a laboratory setting  

With awards season coming to a close in the film and TV industry, pharma gears up for a celebration of its own.

Asahi plans to use the CDMO to propel its bioprocess business

CPHI NA takes place as a SMART event this year, with online learning and networking from May 9-27 and an in-person event from May 17-19 in Philadelphia, PA.  

The UK was the first European country to approve the vaccine from French firm Valneva 

The Musi River flows through Hyderabad in Telangana State, southern India. It is fed by the world heritage Hussain Sagar Lake, known as the 'heart of the world'. 

Global mergers and acquisitions hit an all-time high in 2021, and in the life sciences industry these kinds of deals show no sign of slowing down. 

Several mega-deals have made a splash in the pharma and life sciences industries over recent years – from AstraZeneca’s acquisition of Alexion for $39 billion to Gilead Sciences’ $21 billion purchase of Immunomedics. With am...

Drugmakers have agreed to speed up the market launch of new drugs in underserved EU member states as an alternative to stricter regulation. 

The expansion includes the addition of automated and high-speed production lines. 

What if unpacking medication could be as engaging as unboxing a new iPhone? Could design cues reassure the patient of drug integrity? Step-by-step opening signal ease of use, or empathetic design reduce patient anxiety? 

The expansion will increase production capacity for synthetic pharmaceutical products

The pharma packaging and drug device industry is constantly evolving to optimise drug delivery, keep up with medical advances and ensure regulatory compliance. Trends like sustainability, cost-efficiency and digitisation continue to shape the sector, a...

The pharma packaging and drug delivery industry has gone through many evolutions, most notably to meet the challenges posed by the COVID-19 pandemic over the last two years. Disruptions to global supply chains posed a major issue, combined with a sharp...

The pharma packaging and drug delivery industry has long been synonymous with rapid innovation. As medicine advances and patient needs change, so too should drug packaging and devices.   This has been particularly evident during the pandem...

Data showed that continuous treatment with Kesimpta was associated with fewer relapses and reduced risk of disability worsening 

Construction of Plant 4 – dubbed Super Plant – will be complete in 2023 

TraceLink’s Product Availability Intelligence will enable stakeholders to predict drug shortages months in advance  

Germany forms more than half of the EU’s medical cannabis market  

Sanofi will reduce its stake in EUROAPI to 30% after listing 

Symbiosis, Freeline Therapeutics and Cell and Gene Therapy Catapult joined forces to decrease drug manufacturing timelines

The German healthcare group says the acquisitions will accelerate strategic growth in biopharmaceuticals and MedTech 

International pharma companies may do well to consider setting up shop in the Netherlands, according to data compiled by Mercator by Citco

The FDA also granted paediatric exclusivity to the oral solution, branded Fintepla.  

The expansion will provide additional cold storage and visual inspection capacity, as well as cleanrooms for device assembly and secondary packaging

The expansion will take two years and add 180 new jobs. 

Many clinical trials have been put on hold or cancelled due to the war in Ukraine 

Market set to grow as companies face fewer operational restrictions and COVID-19 drug development continues at pace

Bristol Myers Squibb to leverage Volastra’s CINtech platform to discover and develop oncology drug candidates.  

A redeveloped R&D facility will enhance Seqens' capabilities in developing and producing APIs and active delivery systems development

Having personnel on the ground may be central to mitigating supply chain risks, even as the world embraces the remote approach. 

The CDMO will produce drug substance for clinical supply at its HPAPI manufacturing site in Nansha, China

KKR closes its previously-announced acquisition of Biosynth Carbosynth and announces Biosynth's acquisition of vivitide. 

CellCarta and physIQ announce collaboration on study that could “revolutionise vaccine development.”  

Smart devices are revolutionising how we live our lives and changing the shape of the industries adopting them. One such industry is healthcare, where the benefits of context-aware devices and real-time data sharing are having tangible effects on patie...

The CDMO has expanded its ultra-low temperature commercial packaging, labelling and distribution solutions facility in Ireland

The largest sums of capital were awarded to US biotech companies, followed by companies based in Mainland China and the UK

Moderna announces up to USD $500 million investment for the construction of mRNA vaccine manufacturing facility in Kenya, the first of its kind on the African continent. The facility will be a significant step towards vaccine equity...

The development and cGMP manufacturing laboratories will provide additional early-phase HPAPI manufacturing capabilities

The Taiwan-based nebuliser specialist has signed an MoU with Formosa Laboratories, and Formosa Pharmaceuticals to form a biopharma one-stop-shop

In this month's edition of the CPHI Webinar Series, experts from BioPlan Associates and NIBRT share insights on key trends impacting the biomanufacturing and bioprocessing sector.

Public funding of more than €7 million will help the project to find a solution to prohibitive production costs of developing stem cell-based therapies

The multimillion-dollar deal focuses on potential targeted cancer treatments and makes Huadong the strategic partner in Asia for Heidelberg Pharma’s product development

Contract development and manufacturing organisation Micro-Sphere has invested more than €1.5 million at its plant in Switzerland to expand its offering in encapsulation for inhalation products.

The biopharmaceutical industry has seen incredible growth in the past decade, and shows no sign of slowing as the need for specialised treatments in oncology, immunology and vaccines continue to grow.

By joining forces, the two companies will be able to bring Dispersome to the market faster for novel drug development

The two transactions enable Recipharm to expand its ATMP offering into virotherapies and boost its US biologics services

 $40 million expansion will support increased production of single-use technology for critical vaccines and biologics

The biopharma industry drives development of complex therapies which improve the health outcomes and quality of life of patients across the globe. It is however a significant contributor to environmental waste and emissions as a direct result of it'...

MediCane Health's EU-GMP certification helps to bridge the pharma-cannabis gap

A diverse range of sectors and industries come together in partnership to address infection management, advocating a whole system approach

Formulating a drug for parenteral delivery comes with its fair set of challenges. Aside from a high level of sensitivity to external factors like light and heat exposure, these large and complex drugs are prone to degradation when exposed to various ch...

Travel restrictions imposed by the pandemic have limited the ability of pharmaceutical companies and health authority personnel to travel and conduct in-person inspections of contract manufacturing organizations (CMOs).  Due to t...

COVID-19 saw biopharma turn to single-use technology in a big way. But greater use of disposable manufacturing systems does not necessarily mean drug and vaccine production has become less environmentally sustainable.

The investment covers two expansions to accommodate several pipeline products moving to commercial scale

Cardinal Health says the majority of healthcare providers are keen to use biosimilars despite current market challenges

Adjuvants. You’ve seen them on our website. You’ve seen them featured in our blog articles. Now we want to show you how Avanti’ & Croda-Denmark can enhance your vaccine adjuvant research! Keep reading to learn more!

Speakers from the European Fine Chemicals Group, the voice of fine chemical manufacturers in Europe, led a discussion on the ‘globalised, fragmented and complex’ API and raw materials supply chain, in this month’s edition of the CPHI ...

The $1.5 billion investment will fund a parenteral manufacturing facility in North Carolina and a biopharmaceutical manufacturing site in Ireland

Initial Public Offerings totalled £1,304 million, an increase of 434% from 2020, but more needs to be done to connect the UK's life sciences and finance sectors

Samsung Biologics has reached an agreement for the buyout of Biogen’s stake in the Samsung Bioepis joint venture for USD $2.3 billion.

Xpress Pharmaceutics will facilitate adaptive clinical trials and reduce the time taken to complete FIH studies

The collaboration includes a multimillion-dollar investment to expand glass technology that will advance packaging and delivery systems

The latest coronavirus updates and developments impacting the global pharmaceutical supply chain

The medical journal highlights antimicrobial resistance (AMR) to be a 'leading cause of death around the world'.

The agreement will enable millions of patients in more than 100 low- and middle-income countries to gain access to molnupiravir

Last year the company reduced its electricity requirements by 40%

Astrea Pharma will be the new owner of the facility at Fontaine-lès-Dijon

The CDMO will provide expertise and capacity to advance BravoBio's vaccine pipeline

A quarterly series blog posts about responsible supply chain management from the PSCI Chair, Manjit Singh

Lagevrio and Paxlovid are the only COVID-19 pills cleared for emergency use at present, but others are coming with developers racing to bring oral antivirals to this potentially lucrative market.

The move is expected to bring added value to customers by coupling biology services with existing chemistry capabilities

In this month’s CPHI podcast, sponsored by Galien Pharma, we focus on the technology behind orally dissolving tablets.

This second facility gives the company a significant power multiplier for export capacity and geographical reach

We are approaching the end of a year which saw global vaccine rollout for COVID-19, 44 novel drug approvals (to date) and the return of the CPHI Worldwide in-person event.

Transaction adds new technologies and capabilities in large molecules, including vaccines and gene therapy, to its global offering

This white paper is a retrospective analysis on how the new generation of Molly autoinjectors have incorporated a greater level of flexibility in its design and development model.

New campus will support the company as it approaches potential commercialisation of its rapidly progressing clinical candidates

CDMO currently manufacturing LAAB combination treatment  and will start on cancer immunotherapy product from next year

During the recent CPHI Webinar Packaging & Drug Delivery Trends for 2022 sponsored by Portal Instruments, experts discussed the crucial factors to consider during the development process, such as digitalisation, sustainability and a shift towards self-...

Merck will design the manufacturing process to help accelerate self-sufficient vaccine development and manufacturing in West Africa

The new agreement extends to 2028 and allows Oxord Biomedica to work with other potential partners across all CAR-T targets

The dedicated pharma trade lane will unite key compliant and sector-certified supply chain stakeholders and help Abu Dhabi to strengthen its capabilities as a life sciences hub

The new facility will focus on the research of excipients for oral dosage forms, drug delivery systems, nutraceutical APIs and innovative pharma ingredients

CPHI has launched its forward-looking pharma trend report for 2022 and it is now available to read on CPHI Online.

A 30,000-sq. ft cGMP facility and a separate R&D site will work alongside each other to provide end-to end product development solutions for Singapore and low- and middle-income countries

The facility will be the first to use Evolve’s innovative PlasmaCap EBA technology to produce plasma-derived therapeutics

The combined company intends to lead in the space of oral formulations, solving customers' complex formulation challenges

It could take pharmaceutical companies months to tweak their COVID-19 vaccines to provide sufficient protection against the Omicron variant of the coronavirus if it poses a risk of serious illness.

The new route uses a novel enzyme, cytidine aminotransferase, which would reduce the manufacturing cost of the drug

Lyophilisation or freeze drying is an important means to improve thermal stability of a drug product, according to Thomas Becker, Quality Director and Qualified Person, Recipharm. This is particularly true for those that are thermolabile, such as mRNA ...

The offering will accelerate timelines for the development and manufacturing of molecules and disruptive technologies

The expansion is expected to make the company the largest CDMO in oligonucleotide production in 2025

The new 31,000-sq. ft building will bring additional commercial spray drying capacity for customers who favour US-based manufacturing

In this special edition podcast, Informa Markets pharma editor Gareth Carpenter speaks to Bikash Chatterjee, CEO at Pharmatech Associates and Dan Stanton, Editor and Founder at BioProcess International about some of the findings in the recently pu...

The transaction expands ANI’s R&D pipeline and adds nine new customers to its growing CDMO business

The facility's total 60,000-L capacity supports growing demand for manufacture of late-phase and commercial projects

China is the pharma industry’s biggest gainer in the 2021 CPHI Annual Rankings, with digital matchmaking driving new waves of partnerships

CPHI Verified certification improves supply chain transparency, providing a legal, regulatory and quality benchmark

The state-of-the-art centre will be built in Prince Edward Island to support domestic biomanufacturing capabilities

New Zebra study shows the pharmaceutical industry has a trust problem, but industry leaders say they’re trying to become more transparent

The expansion includes the installation of a pilot suite with a 50-L fermenter and automation upgrades to accelerate clinical and commercial projects

SK's financial backing enables CBM to address significant capacity constraints in the cell and gene therapy manufacturing space

The proposed state-of-the-art facility could potentially produce up to 100 million vaccine doses each year for Australians

Company says it has concluded virus is in endemic phase and it is the ‘right time’ to switch

WuXi will use its new modality platform to provide an end-to-end solution for oligonucleotide peptide

The CDMO will raise its headcount to 8,000 across its 19 global facilities amid increased demand for services

Awards seek to recognise ‘Excellence in Pharma’, assessing entries from the industry’s leading companies and individuals.

The $20.1 million investment will enable the company to manufacture pharma products for the Adcock Ingram Group and for other clients

The transaction will support Cannabics' planned IND fillings and Phase I/II (a) clinical trials

The first-of-its-kind centre will offer biopharma clients convenience and efficiencies in the rapidly expanding Northeast

The increasing outsourcing trend among pharmaceutical companies represents a promising opportunity for CDMOs. This panel discussion at CPHI Worldwide touched upon some of the opportunities, hurdles, and trends ahead for the CDMO market

Expected increase in approvals for gene therapies, gene-modified cell therapies and recombinant vector vaccines will also increase pressure on manufacturers to build new capacity

The CDMO says the suite will help to "bring back manufacturing to the US"